PubRank

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Clinical Trial ID NCT00813891

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00813891

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global data on visual impairment in the year 2002. Bull World Health Organ 2004 28.05
2 Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004 18.86
3 Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004 13.78
4 The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004 5.86
5 Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001 4.04
6 Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996 3.21
7 Age-related macular degeneration is the leading cause of blindness... JAMA 2004 3.18
8 Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 2003 3.17
9 Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996 2.87
10 Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997 2.73
11 Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002 2.57
12 Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997 2.28
13 Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 2003 2.20
14 Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996 1.90
15 VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 2003 1.71
16 Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004 1.64
17 Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001 1.53
18 Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002 1.37
19 Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res 2002 1.21
Next 100